• Welcome to Renmin Hospital of Wuhan University
  • 网站首页 中文版 English Francaise
  • 万珊珊 眼科学
    副教授、副主任医师、硕士生导师
    A+ A-
    导师介绍

    姓名 万珊珊
    出生年月 1989年5月
    单位 武汉大学人民医院眼II科
    所属学科 临床医学-眼科学
    职务、职称及头衔 副教授、副主任医师、硕士生导师
    E-mail ophwss@whu.edu.cn
    联系方式 027-88041911转81217
    研究方向 1.眼表疾病的基础与临床
    2.角膜移植
    个人简介 师从中国工程院院士谢立信教授,长期从事角膜与眼表疾病的基础与临床研究。主持国家自然科学基金青年项目1项,参与国家自然科学基金面上项目2项、教育部产学协同育人计划课题、全国医学教育发展中心课题等。以第一作者、通讯作者发表SCI论文7篇,均为中科院2区。副主编专著1部。已协助培养硕士生5名,其中3名通过国家公派留学基金委资助,赴国外继续攻读博士学位。
    学术任职与荣誉 中国医师协会眼科医师分会眼感染学组青年委员
    教育履历 2007.09-2012.06湖北医药学院临床医学专业本科生获学士学位
    2012.09-2015.06武汉大学第一临床学院眼科学硕士研究生获硕士学位
    2016.09-2019.06武汉大学第一临床学院眼科学博士研究生获博士学位
    工作履历 2015.07-2016.08武汉大学人民医院眼II科 住院医师
    2019.07-2021.11武汉大学人民医院眼II科主治医师
    2021.12-至今武汉大学人民医院眼II科副主任医师
    2022.12-至今武汉大学人民医院眼II科副教授
    成果获奖 1. 2022年全国角膜及眼表疾病学术大会青年医师演讲大赛全国一等奖
    2. 2019年“慕明而来非凡友你”病例征集赛全国总决赛二等奖
    代表性论著 (1).Wang, Yang;Gao, Yuelan;Huang, Yuqing;Pan, Yumiao;Yu, Yi;Zhou, Yiwen;Wan, Shan-shan*;Yang, Yan-ning*.(2021/5).The potential protective effects of miR-497 on corneal neovascularization are mediated via macrophage through the IL-6/STAT3/VEGF signaling pathway.INTERNATIONAL IMMUNOPHARMACOLOGY ( SCIE二区,影响因子: 5.714)共同通讯作者
    (2).Wan, Shan-Shan;Pan, Yu-Miao;Yang, Wan-Ju;Rao, Zhuo-Qun;Yang, Yan-Ning*.(2020/6).Inhibition of EZH2 alleviates angiogenesis in a model of corneal neovascularization by blocking FoxO3a-mediated oxidative stress.FASEB JOURNAL ( SCIE二区,影响因子: 5.192)第一作者
    (3).Wan, Shanshan;Zhou, Yiwen;Huang, Qiong;Yang, Yanning*.(2021/2).Dot1l Aggravates Keratitis Induced by Herpes Simplex Virus Type 1 in Mice via p38 MAPK-Mediated Oxidative Stress.OXIDATIVE MEDICINE AND CELLULAR LONGEVITY ( SCIE二区,影响因子: 7.31)第一作者
    (4).Wan, Shanshan;Yang, Wanju;Pan, Yumiao;Rao, Zhuoqun;Yang, Yanning*.(2020/3).G9a Suppression Alleviates Corneal Neovascularization through Blocking Nox4-Mediated Oxidative Stress.OXIDATIVE MEDICINE AND CELLULAR LONGEVITY ( SCIE二区,影响因子: 6.543)第一作者
    Name Shanshan Wan
    Date of birth May,1989
    Department Ophthalmology Department,Renmin Hospital,Wuhan University.
    Title Associated Professor, Master tutor
    Email ophwss@whu.edu.cn
    TEL 027-88041911-81217
    Research Direction 1. The basis and clinic of ocular surface diseases
    2. Corneal transplantation
    Personal Profile Under the training of Professor Xie Lixin, academician of Chinese Academy of Engineering, she has been engaged in basic and clinical research of corneal and ocular surface diseases for a long time. She presided over one National Natural Science Foundation youth project, and participated in National Natural Science Foundation project, the Ministry of Education's industry-University collaborative education program and the National Medical Education Development Center. She has published 7 SCI papers as the first author and corresponding author, all of which are in the 2nd district of the Chinese Academy of Sciences. Associate editor monograph 1. She have assisted in training 5 master students, 3 of whom have been funded by the China Scholarship Council to continue their doctoral studies abroad.
    Selected Publications (1).Wang, Yang;Gao, Yuelan;Huang, Yuqing;Pan, Yumiao;Yu, Yi;Zhou, Yiwen;Wan, Shan-shan*;Yang, Yan-ning*.(2021/5).The potential protective effects of miR-497 on corneal neovascularization are mediated via macrophage through the IL-6/STAT3/VEGF signaling pathway.INTERNATIONAL IMMUNOPHARMACOLOGY
    (2).Wan, Shan-Shan;Pan, Yu-Miao;Yang, Wan-Ju;Rao, Zhuo-Qun;Yang, Yan-Ning*.(2020/6).Inhibition of EZH2 alleviates angiogenesis in a model of corneal neovascularization by blocking FoxO3a-mediated oxidative stress.FASEB JOURNAL
    (3).Wan, Shanshan;Zhou, Yiwen;Huang, Qiong;Yang, Yanning*.(2021/2).Dot1l Aggravates Keratitis Induced by Herpes Simplex Virus Type 1 in Mice via p38 MAPK-Mediated Oxidative Stress.OXIDATIVE MEDICINE AND CELLULAR LONGEVITY
    (4).Wan, Shanshan;Yang, Wanju;Pan, Yumiao;Rao, Zhuoqun;Yang, Yanning*.(2020/3).G9a Suppression Alleviates Corneal Neovascularization through Blocking Nox4-Mediated Oxidative Stress.OXIDATIVE MEDICINE AND CELLULAR LONGEVITY